Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Novavax, Inc. (NVAX)

-NasdaqGS
4.54 0.22(5.09%) Jul 23, 4:00PM EDT
Prev Close:4.32
Open:4.35
Bid:4.48 x 100
Ask:4.74 x 100
1y Target Est:11.00
Beta:1.17
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:4.33 - 4.55
52wk Range:2.24 - 6.95
Volume:2,788,287
Avg Vol (3m):4,069,100
Market Cap:949.95M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXUp 5.09%949.95M
MRK169.82B
NVS215.98B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):36.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.27
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback